MK
Maha Katabi

Maha Katabi insider trades: Vera Therapeutics (VERA) stock buys and sales

Vera Therapeutics Last trade Mar 25, 2024 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2020
7
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Maha reports to the SEC

and 1 more company

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 25, 2024VERA↓ Sell$34.1M
Jan 30, 2024VERA↑ Buy$5.0M
Sep 19, 2023RYZB↑ Buy$4.2M
Feb 6, 2023VERA↑ Buy$2.0M
Nov 28, 2022CINC↓ Sell$86K
Aug 11, 2022CINC↑ Buy$15.0M
Feb 10, 2022VERA↑ Buy$4.0M
Jan 11, 2022CINC↑ Buy$5.2M
Jul 2, 2021AVTE↑ Buy$5.0M
May 18, 2021VERA↑ Buy$8.0M
Feb 9, 2021BOLT↑ Buy$9.0M
Jul 28, 2020INZY↑ Buy$7.0M
Jun 30, 2020AKUS↑ Buy$1000K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VERA insiders

Open-market trades in the last 12 months

About Maha Katabi's insider trades

Maha Katabi is an insider at Vera Therapeutics (VERA). Since Jun 30, 2020, Maha has reported 11 open-market purchases worth $65.4M and 2 sales worth $34.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (14 filings), conversions (7 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VERA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.